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Marfan syndrome is one of the most common inherited autosomal genetic disorders of the connective 
tissue. The syndrome is inherited as a dominant 
trait, carried by the gene FBN1, which encodes 
the connective protein fibrillin-1. Marfan has 
a reported incidence of 1 in 3,000 to 5,000 
individuals.1–2 Sufferers tend to be unusually tall, 
with long limbs and fingers. Marfan affects many 
different organ systems; however, cardiovascular 
disease, particularly aortic root disease—leading 
to aneurysmal dilatation, aortic regurgitation, 
and dissection—is the main cause of morbidity 
and mortality associated with this disorder. The 
progressive and potentially fatal complications of 
Marfan syndrome warrant an early diagnosis. It 
demonstrates the role of the family physician in 
making a correct diagnosis of the disease, despite 
late presentation, and the importance of proper 
follow-up, referral, and counselling.
Case Report
A 39-year-old Omani man presented to the 
Family Medicine Clinic of Sultan Qaboos 
University Hospital complaining of a dry cough 
and progressive shortness of breath for 5 days. His 
shortness of breath was manifesting as orthopnoea 
and paroxysmal nocturnal dyspnoea. He reported 
that this was the first time he had experienced these 
problems. The patient denied having any chest 
pain and was not known to have any cardiac or 
respiratory disease, nor had he any history of prior 
hospitalisation. His four brothers had all died of 
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متالزمة مارفان - تقرير ألول حالة من ُعمان
 التشخيص الصحيح ميكن أن ينقذ حياة
نفي�صة �صمري، وفاء اآلفنة، ثورد ثيودور�صن، عبد العزيز املحرزي
امللخ�ض: متالزمة مارفان ا�صطراب وراثي ي�صيب االأن�صجة ال�صاّمة ويوؤثر على العديد من اأجهزة اجل�صم. ومع ذلك، فاإن اأكرث امل�صاعفات 
االأَْبَهر  َت�َصلُِّخ  اإىل  يوؤدي  قد  االأبهر، مما  ال�رصيان  التدريجي جلذر  التو�صيع  هو  مارفان  يعانون من متالزمة  الذين  املر�صى  لدى  اخلطرية 
ومتزقه، اأو ح�صول الَقَل�ُض االأَْبَهِرّي. اإّن الوقاية من هذه امل�صاعفات التي تهدد احلياة مهم جدا يف عالج هذه احلالة. ُندرج هنا حالة رجل 
ُعماين يبُلغ من الُعُمر 39 عاما م�صابا مبتالزمة مارفان، وكان بحاجة اإىل العناية الطبية نظرا الإ�صابته ب�صيق تدريجي يف التنف�ض، وقد 
اأجريت له عملية جراحية ُكربى ناجحة يف القلب. من املهم جدا ت�صخي�ض متالزمة مارفان مبكرا من اأجل اتخاذ اإجراءات وقائية ممكنة 
قبل حدوث امل�صاعفات.
مفتاح الكلمات: متالزمة مارفان، َت�َصلُُّخ االأَْبَهر، اأم الدم االأبهري، مالمح متالزمة مارفان، علم جنت لت�صنيف االأمرا�ض، تقرير حالة، ُعمان.
abstract: Marfan syndrome is a heritable disorder of the connective tissue that affects many systems of the 
body. However, the most serious complication in patients with Marfan syndrome is progressive enlargement of the 
aortic root, which may lead to aortic dissection, rupture, or aortic regurgitation. Prevention of these life threatening 
complications is very important in the management of this condition. A 39-year-old Omani man presented 
with progressive shortness of breath and eventually underwent major but successful cardiac surgery. It is very 
important to recognise Marfan syndrome early as preventive actions are possible if the condition is diagnosed 
before complications occur.
Keywords: Marfan syndrome; Aortic dissection; Aortic aneurysm; Marfanoid habitus; Case report; Oman.
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unknown causes before reaching their first year of 
life and his mother had died suddenly at the age of 
64. His maternal uncle had died suddenly at age 25. 
The patient is the father of three children. He had 
no family history of hypertension, diabetes, heart 
disease, or any known inherited disorder. 
On examination, the patient’s respiratory rate 
was 24 breaths per minute with a collapsing pulse 
and a rate of 80 beats per minute. His blood pressure 
was 115/60 mmHg and oxygen saturation was 97%. 
He had a height of 182 cm and an arm span of 194 
cm, giving him an arm span to height ratio of 1.06. 
He had hypermobile joints, a positive thumb sign, 
and a high arched palate with some element of 
teeth crowding. The patient had a pectus carinatum 
deformity and auscultation of the lungs revealed 
bilateral basal crepitations. A cardiovascular 
examination revealed a displaced heaving apex, 
dual heart sounds with palpable pulsation at the 
right parasternal area, a mid-systolic murmur and 
a Grade 3–4/6 early diastolic murmur which was 
best heard at the right sternal area radiating to the 
carotid. He had no pedal oedema. 
An electrocardiogram (ECG) displayed a sinus 
rhythm with a heart rate of 80 beats per minute, 
but no other significant abnormality. A chest 
X-ray [Figure 1] showed mediastinal widening and 
cardiomegaly with interstitial pulmonary oedema. 
A troponin I assay was negative. He was assessed 
by the cardiologist on call. Left ventricular failure 
was suspected at that stage and intravenous 
furosemide was administered to the patient which 
led to significant improvement; therefore, he was 
discharged home on furosemide and carvedilol. 
Four weeks later, a transthoracic echocardiogram 
(TTE) was performed which showed a severely 
dilated left ventricle, severe aortic regurgitation, a 
dilated aortic root, and an ascending aorta (82 mm) 
with aortic dissection extending from the root to 
the ascending aorta. The patient was immediately 
sent for a contrast enhanced computed tomography 
(CT) of the chest. It demonstrated a large aneurysm 
of the ascending aorta measuring 9.9 x 9 cm with 
dissection and minimal pericardial effusion [Figures 
2 and 3]. The aortic arch and descending aorta were 
both normal. As a result, the patient was urgently 
Figure 1: Frontal chest X-ray showing mediastinal 
widening (top arrow) and dilatation of the ascending 
aorta (middle arrow) with signs of heart failure (bottom 
arrow). 
Figure 2: Axial computed tomography (CT) image 
through ascending (AA) and descending (DA) thoracic 
aorta showing the aneurysmal dilatation of the 
ascending aorta (top-right arrow) with intimal flap (type 
A dissection, top-left arrow) and pericardial effusion 
(middle arrow). Compare the diameter of ascending 
aorta with descending aorta (bottom arrow). 
Figure 3: Coronal reformat of the same computed 
tomography (CT) chest scan showing the extent of the 
aneurysmal dilatation of the ascending aorta as well as 
the dissection (both arrows).
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referred for surgical intervention. He underwent 
a Bentall procedure that involved a composite 
graft replacement of the aortic valve, aortic root, 
and ascending aorta, with re-implantation of 
the coronary arteries into the graft. The patient 
recovered well from this major surgery with 
significant improvement of his symptoms. A post-
operative chest X-ray also showed a remarkable 
improvement [Figure 4]. The patient was discharged 
on the seventh postoperative day. 
Following surgery, the patient was examined by 
an ophthalmologist. He was found to have myopia 
of -2.5 diopters but had no signs of ectopia lentis 
or any other ocular features of Marfan syndrome. 
Screening of other family members was arranged 
and two of his children, aged 4 and 5 years, were 
found to have Marfanoid features along with aortic 
root dilatation on echo; they are currently being 
treated by a paediatric cardiologist. 
Discussion
Marfan syndrome deserves particular attention 
by primary care physicians for two reasons. First, 
primary care is considered a patient’s first portal 
of entry into the health care system. Second, there 
are helpful clinical clues that make it a screenable 
condition for primary care physicians. 
The Ghent criteria [Table 1] represent the 
standard for diagnosing Marfan syndrome 
in accordance with clinical signs and family 
history.3–4 They employs a set of major and minor 
manifestations in numerous tissues, including the 
skeletal, ocular, cardiovascular, and pulmonary 
systems, and the dura, skin and integument. 
Diagnosis is made if major criteria are identified in 
at least two different organ systems, and if there is 
involvement of a third organ system with either a 
major or minor manifestation. If a family history 
of Marfan syndrome is positive then involvement 
Table 1: Major and minor Ghent criteria for the diagnosis of Marfan syndrome
Criteria Major Minor
Skeletal Four of the following eight skeletal system features:
 
• Upper to lower body segment ratio <0.85 or arm 
span-height ratio >1.05
• Scoliosis >20° or spondylolisthesis
• Arachnodactyly of fingers and toes, with positive 
thumb* and wrist signs
• Pes planus due to medial malleolus displacement
• Reduced extension at the elbows (<170º)  
• Pectus excavatum requiring surgical intervention
• Pectus carinatum 
•Protrusio acetabuli 
2 of the major features, or 1 major feature and 2 of 
the following:
• Moderate pectus excavatu
• Joint hypermobility
•High arched palate with crowding of teeth
•Facial features like dolichocephaly, malar 
hypoplasia, enophthalmos, retrognathia, or down-
slanting palpebral fissures
Cardiovascular •Dilatation of the aorta with or without aortic 
regurgitation
•Ascending aortic dissection
• Mitral valve prolapse
• Mitral regurgitation
• Calcification of the mitral valve before age 40           
• Dilatation of pulmonary artery before age 40           
• Dilatation/dissection of descending aorta before 
age 50
Ocular Ectopia lentis •Flat cornea                         
•Increased axial length of globe  
• Hypoplastic iris or ciliary muscle 
•Myopia                                 
•Retinal detachment.
Pulmonary None •Spontaneous pneumothorax   
•Apical blebs
Skin/Integument None •Cutaneous striae distensae
•Recurrent or incisional hernia
Dura •Lumbosacral dural ectasia None
Source: Ades L. CSANZ Cardiovascular Genetics Working Group. Guidelines for the diagnosis and management of Marfan syndrome.3
* = Positive thumb sign: entire thumbnail protrudes beyond ulnar border of clenched fist; ¶ = Positive wrist sign: thumb and fifth digit overlap when 
encircling the wrist.
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of only two organ systems, including one major 
criterion, is necessary for diagnosis.3–4 Any doubt 
in the clinician's assessment warrants further 
diagnostic evaluation. 
Over the past 30 years, advances in medical 
and surgical management of the cardiovascular 
problems, especially mitral valve prolapse, aortic 
dilatation, and aortic dissection, together with a 
reduction of physical and haemodynamic stresses 
have resulted in remarkable improvement in life 
expectancy of Marfan syndrome sufferers.5–6
It is incumbent on the physicians who encounter 
these patients to emphasise preventive measures. 
These include periodic imaging of the aorta in order 
to evaluate its size and the progression of aortic 
enlargement; early administration of beta blockers 
mainly to delay aortic root enlargement, and 
prophylactic surgical repair when there is a high risk 
of dissection, rupture, or serious aortic regurgitation 
due to aortic dilatation.7 Other pharmacological 
agents, such as angiotensin-converting enzyme 
inhibitors (ACEI), angiotensin receptor blockers 
(ARB), and calcium-channel blockers (CCB) have 
all been used in patients who have unacceptable 
adverse events or no response to beta-blockers.7–11 
Initially, a biannual TTE is recommended to 
determine the rate of aortic dilation; thereafter, an 
annual TTE is recommended if aortic size remains 
stable. In instances of aortic dilatation of more than 
45 mm, more frequent imaging of the aorta should 
be considered as rapid increase in size portends 
an increased risk of dissection.10 Owing to these 
preventive measures, life expectancy has improved 
considerably.6,12
Patients diagnosed with Marfan syndrome 
should have appropriate counselling before 
choosing a career. Physically demanding jobs 
should be avoided. These patients should also be 
cautioned against participating in high intensity 
exercise, particularly isometric exercises. Instead, 
they should be encouraged to participate in lower 
intensity dynamic exercise.13 It is important for 
primary health care providers to be aware of the 
current recommendations related to physical 
activity in these patients.14
Our case illustrates the importance of making a 
correct diagnosis of Marfan syndrome. The initial 
assessment should include a comprehensive medical 
history that includes a personal and family history 
of cardiovascular disease. Clinical assessment 
should include recognition of the physical stigmata 
of Marfan syndrome, an eye examination, and a 
TTE.
The primary care physician can play a crucial 
role in the early detection of this syndrome and is 
also important in facilitating a multi-disciplinary 
approach through coordination of care with other 
health care professionals. In addition, the primary 
health care provider should be aware of the 
availability of pharmacological means to prevent or 
delay aortic dilatation. 
Conclusion
It is very important to recognise Marfan syndrome 
early. Despite the morbidity and mortality 
associated with Marfan syndrome, early medical 
and surgical management can improve the life 
expectancy of many patients. Advancing research 
holds the promise of further improvements. This 
case illustrates the importance of obtaining a 
complete family history, and the value of clinical 
correlation while assessing patients with unusual 
physical findings. Early diagnosis of this disease 
by physicians will help in initiating treatment 
and appropriate management, including patient 
education and genetic counselling, and will provide 
an opportunity for family screening.
informed consent
Informed consent was obtained from the patient to 
publish this case report. 
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